Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction

Circulation Journal

Volumn 77, Issue 4, 2013, Pages 1026-1032

  Matsumoto, Sen ^a   Nakatani, Daisaku ^a   Sakata, Yasuhiko ^a   Suna, Shinichiro ^a   Shimizu, Masahiko ^a   Usami, Masaya ^a   Hara, Masahiko ^a   Sumitsuji, Satoru ^a   Nanto, Shinsuke ^a   Sasaki, Tatsuya ^b   Hamasaki, Toshimitsu ^a   Sato, Hiroshi ^c   Hori, Masatsugu ^d   Komuro, Issei ^a  

^a OSAKA UNIVERSITY   (Japan)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^c KWANSEI GAKUIN UNIVERSITY   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Acute myocardial infarction; Cardiac event; Heart type fatty acid binding protein

Indexed keywords

CREATINE KINASE; FATTY ACID BINDING PROTEIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONVALESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITAL READMISSION; HUMAN; IMMUNOASSAY; INFLAMMATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CONVALESCENCE; DISEASE-FREE SURVIVAL; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84875488498     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0999     Document Type: Article

References (27)

1. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991; 1081: 1-24.
2. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction: Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000; 38: 231-238.
3. Inoue K, Suwa S, Ohta H, Itoh S, Maruyama S, Masuda N, et al. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ J 2011; 75: 2813-2820.
4. Nishinari M, Aoyama N, Ogawa Z, Yukino S, Oka S, Yano K, et al. Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction. Circ J 2012; 76: 2197-2203.
5. Ecollan P, Collet JP, Boon G, Tanguy ML, Fievet ML, Haas R, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol 2007; 119: 349-354.
6. Seino Y, Tomita Y, Takano T, Ohbayashi K. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: Comparison between hearttype fatty acid-binding protein and troponin T tests. Circ J 2004; 68: 144-148.
7. Mion MM, Novello E, Altinier S, Rocco S, Zaninotto M, Plebani M. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. Clin Biochem 2007; 40: 1245-1251.
8. Haastrup B, Gill S, Kristensen SR, Jorgensen PJ, Glatz JF, Haghfelt T, et al. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000; 94: 254-261.
9. Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 2007; 50: 2061-2067.
10. O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550-557.
11. Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010; 55: 2590-2598.
12. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002; 113: 717-722.
13. Setsuta K, Seino Y, Ogawa T, Ohtsuka T, Seimiya K, Takano T. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circ J 2004; 68: 747-750.
14. Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, et al. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 2007; 13: 120-127.
15. Shiozaki M, Iso H, Ohira T, Nakatani D, Shimizu M, Sakata Y, et al. Longitudinal risk of cardiovascular events in relation to depression symptoms after discharge among survivors of myocardial infarction: Osaka Acute Coronary Insufficiency Study. Circ J 2011; 75: 2878-2884.
16. Kurotobi T, Sato H, Kinjo K, Nakatani D, Mizuno H, Shimizu M, et al. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol 2004; 44: 28-34.
17. Nakatani D, Sakata Y, Mizuno H, Shimizu M, Suna S, Usami M, et al. Impact of diabetes mellitus on rehospitalization for heart failure among survivors of acute myocardial infarction in the percutaneous coronary intervention era. Circ J 2009; 73: 662-666.
18. Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol 2007; 99: 885-889.
19. Sakata Y, Nakatani D, Shimizu M, Suna S, Usami M, Matsumoto S, et al. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. J Cardiol 2012; 59: 14-21.
20. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446.
21. Hosmer D, Lemeshow S. Applied logistic regression, 2nd edition. New York: John Wiley & Sons, 2000.
22. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Proceedings of Fourteenth International Joint Conference on Artificial Intelligence (IJCAI). San Francisco: Morgan Kaufmann Publishers, 1995; 1137-1143.
23. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
24. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JF. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997; 43: 193-195.
25. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116: 155-162.
26. Akbal E, Ozbek M, Gunes F, Akyurek O, Ureten K, Delibasi T. Serum heart type fatty acid binding protein levels in metabolic syndrome. Endocrine 2009; 36: 433-437.
27. Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, et al. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clin Chem 2009; 55: 265-273.